Evidence map›Paper›PMID 36195757›Full record

ArticleNature genetics2022

Gain-of-function mutations in KCNK3 cause a developmental disorder with sleep apnea.

Janina Sörmann, Marcus Schewe, Peter Proks, Thibault Jouen-Tachoire, Shanlin Rao, Elena B Riel, Katherine E Agre, Amber Begtrup, John Dean, Maria Descartes and 20 more

Open access · hybridAbstract read
In one paragraph

Article in Nature genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Structural basis for proton inhibition of the two-pore domain KStructure (London, England : 1993) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Structure of the human KNature structural & molecular biology · 2025
    Article
  10. Article
  11. Food sensing controlsScience advances · 2025
    Article
  12. Article
  13. Article
  14. Development of covalent chemogenetic KCell chemical biology · 2024
    Article
  15. Structure of the human KbioRxiv : the preprint server for biology · 2024
    Article
  16. Development of covalent chemogenetic KbioRxiv : the preprint server for biology · 2023
    Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors at 14 institutions in 3 countries.

Janina SörmannClarendon Laboratory, Department of Physics, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-3288-6681
Marcus ScheweInstitute of Physiology, Faculty of Medicine, Kiel University, Kiel, Germany.ORCID http://orcid.org/0000-0002-6192-5651
Peter ProksClarendon Laboratory, Department of Physics, University of Oxford, Oxford, UK.
Thibault Jouen-TachoireClarendon Laboratory, Department of Physics, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-5867-994X
Shanlin RaoDepartment of Biochemistry, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-4892-5523
Elena B RielInstitute of Physiology, Faculty of Medicine, Kiel University, Kiel, Germany.ORCID http://orcid.org/0000-0003-3227-9344
Katherine E AgreMayo Clinic, Rochester, MN, USA.
Amber BegtrupGeneDx, Gaithersburg, MD, USA.ORCID http://orcid.org/0000-0002-2872-3281
John DeanDepartment of Medical Genetics, NHS Grampian, Aberdeen, UK.
Maria DescartesDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA.
Jan FischerInstitute for Clinical Genetics, Universitätsklinikum, Technischen Universität Dresden, Dresden, Germany.
Alice GardhamNorth West Thames Regional Genetics Service, London North West Healthcare NHS Trust, London, UK.
Carrie LahnerMayo Clinic, Rochester, MN, USA.
Paul R MarkSpectrum Health Medical Genetics, Grand Rapids, MI, USA.ORCID http://orcid.org/0000-0002-1020-888X
Srikanth MuppidiStanford Neurosciences Health Center, Palo Alto, CA, USA.
Pavel N PichurinMayo Clinic, Rochester, MN, USA.
Joseph PorrmannInstitute for Clinical Genetics, Universitätsklinikum, Technischen Universität Dresden, Dresden, Germany.
Jens SchallnerDepartment of Neuropediatrics, Universitätsklinikum, Technischen Universität Dresden, Dresden, Germany.
Kirstin SmithDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA.
Volker StraubInstitute of Translational and Clinical Research, Newcastle University, Newcastle upon Tyne, UK.ORCID http://orcid.org/0000-0001-9046-3540
Pradeep VasudevanUniversity Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, Leicester, UK.
Rebecca WillaertGeneDx, Gaithersburg, MD, USA.
Elisabeth P CarpenterOXION Initiative in Ion Channels and Disease, University of Oxford, Oxford, UK.
Karin E J RödströmCentre for Medicines Discovery, University of Oxford, Oxford, UK.
Michael G HahnBayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany.
Thomas MüllerBayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany.ORCID http://orcid.org/0000-0001-9017-4781
Thomas BaukrowitzInstitute of Physiology, Faculty of Medicine, Kiel University, Kiel, Germany.
Matthew E HurlesHuman Genetics Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.ORCID http://orcid.org/0000-0002-2333-7015
Caroline F WrightInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK. caroline.wright@exeter.ac.uk.ORCID http://orcid.org/0000-0003-2958-5076
Stephen J TuckerClarendon Laboratory, Department of Physics, University of Oxford, Oxford, UK. stephen.tucker@physics.ox.ac.uk.ORCID http://orcid.org/0000-0001-8996-2000
University of Oxford · GBChristian-Albrechts-Universität zu Kiel · DEKlinik und Poliklinik für Psychotherapie und Psychosomatik · DEMayo Clinic in Arizona · USBayer (Germany) · DEUniversity of Alabama at Birmingham · USLeicester Royal Infirmary · GBLondon North West Healthcare NHS Trust · GBNewcastle University · GBNHS Grampian · GBSpectrum Health · USStanford Health Care · USUniversity of Exeter · GBWellcome Sanger Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/S008608/1Biotechnology and Biological Sciences Research Council BB/T002018/1Department of HealthMedical Research Council MR/W017741/1Wellcome TrustWellcome Trust 102161/B/13/ZWellcome Trust WT084655MAWellcome Trust WT098051
6 · The paper itself

Abstract

Sleep apnea is a common disorder that represents a global public health burden. KCNK3 encodes TASK-1, a K

Indexed as

Gain of Function MutationSleep Apnea SyndromesChildDevelopmental DisabilitiesHumansMutationNerve Tissue ProteinsPotassium Channels, Tandem Pore DomainNerve Tissue ProteinsPotassium Channels, Tandem Pore Domainpotassium channel subfamily K member 3

Identifiers

PMID36195757
PMCPMC9534757
OpenAlexW4301179097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.